Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.21396542 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.21396542 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.87921074 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.87921074 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.50151479 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.50089175 |
7 | * very-low-density lipoprotein particle assembly (GO:0034379) | 6.17953297 |
8 | urea metabolic process (GO:0019627) | 5.91297442 |
9 | urea cycle (GO:0000050) | 5.91297442 |
10 | tryptophan catabolic process (GO:0006569) | 5.87469670 |
11 | indole-containing compound catabolic process (GO:0042436) | 5.87469670 |
12 | indolalkylamine catabolic process (GO:0046218) | 5.87469670 |
13 | bile acid biosynthetic process (GO:0006699) | 5.86820099 |
14 | kynurenine metabolic process (GO:0070189) | 5.79826744 |
15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.74596452 |
16 | * low-density lipoprotein particle remodeling (GO:0034374) | 5.66523916 |
17 | glyoxylate metabolic process (GO:0046487) | 5.56727682 |
18 | regulation of apoptotic cell clearance (GO:2000425) | 5.56277112 |
19 | tryptophan metabolic process (GO:0006568) | 5.55778977 |
20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.55404786 |
21 | negative regulation of fibrinolysis (GO:0051918) | 5.46261499 |
22 | nitrogen cycle metabolic process (GO:0071941) | 5.41554512 |
23 | regulation of protein activation cascade (GO:2000257) | 5.38850921 |
24 | cysteine metabolic process (GO:0006534) | 5.38427865 |
25 | complement activation, alternative pathway (GO:0006957) | 5.34131510 |
26 | * protein-lipid complex subunit organization (GO:0071825) | 5.25412577 |
27 | regulation of fibrinolysis (GO:0051917) | 5.24859560 |
28 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.22139389 |
29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17129967 |
30 | protein carboxylation (GO:0018214) | 5.17129967 |
31 | sulfur amino acid catabolic process (GO:0000098) | 5.15584000 |
32 | regulation of cholesterol esterification (GO:0010872) | 5.10352297 |
33 | bile acid metabolic process (GO:0008206) | 5.09895795 |
34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.08241041 |
35 | homocysteine metabolic process (GO:0050667) | 5.07671065 |
36 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.04623011 |
37 | regulation of complement activation (GO:0030449) | 5.02083629 |
38 | intestinal absorption (GO:0050892) | 5.00464997 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.99267649 |
40 | reverse cholesterol transport (GO:0043691) | 4.99199183 |
41 | serine family amino acid catabolic process (GO:0009071) | 4.98431095 |
42 | regulation of plasminogen activation (GO:0010755) | 4.91909688 |
43 | phospholipid efflux (GO:0033700) | 4.89002033 |
44 | aromatic amino acid family metabolic process (GO:0009072) | 4.71845776 |
45 | negative regulation of sterol transport (GO:0032372) | 4.68799652 |
46 | negative regulation of cholesterol transport (GO:0032375) | 4.68799652 |
47 | diacylglycerol metabolic process (GO:0046339) | 4.64750963 |
48 | bile acid and bile salt transport (GO:0015721) | 4.64406135 |
49 | * protein-lipid complex remodeling (GO:0034368) | 4.64145882 |
50 | * macromolecular complex remodeling (GO:0034367) | 4.64145882 |
51 | * plasma lipoprotein particle remodeling (GO:0034369) | 4.64145882 |
52 | amino-acid betaine metabolic process (GO:0006577) | 4.63519423 |
53 | triglyceride homeostasis (GO:0070328) | 4.62725015 |
54 | acylglycerol homeostasis (GO:0055090) | 4.62725015 |
55 | lysine metabolic process (GO:0006553) | 4.59256109 |
56 | lysine catabolic process (GO:0006554) | 4.59256109 |
57 | tyrosine metabolic process (GO:0006570) | 4.58567552 |
58 | alpha-amino acid catabolic process (GO:1901606) | 4.50304201 |
59 | glycine metabolic process (GO:0006544) | 4.32587962 |
60 | cellular glucuronidation (GO:0052695) | 4.32346809 |
61 | * cholesterol efflux (GO:0033344) | 4.30917709 |
62 | cellular ketone body metabolic process (GO:0046950) | 4.23671999 |
63 | glutamate metabolic process (GO:0006536) | 4.21421249 |
64 | imidazole-containing compound metabolic process (GO:0052803) | 4.20586994 |
65 | indolalkylamine metabolic process (GO:0006586) | 4.17927340 |
66 | * plasma lipoprotein particle clearance (GO:0034381) | 4.17482922 |
67 | intestinal cholesterol absorption (GO:0030299) | 4.16343759 |
68 | coenzyme catabolic process (GO:0009109) | 4.14477445 |
69 | negative regulation of blood coagulation (GO:0030195) | 4.14393042 |
70 | negative regulation of hemostasis (GO:1900047) | 4.14393042 |
71 | cellular amino acid catabolic process (GO:0009063) | 4.14118684 |
72 | serine family amino acid metabolic process (GO:0009069) | 4.12890045 |
73 | drug catabolic process (GO:0042737) | 4.11772056 |
74 | phospholipid homeostasis (GO:0055091) | 4.10472357 |
75 | regulation of humoral immune response (GO:0002920) | 4.10258872 |
76 | acute-phase response (GO:0006953) | 4.06535588 |
77 | cellular biogenic amine catabolic process (GO:0042402) | 4.03164263 |
78 | amine catabolic process (GO:0009310) | 4.03164263 |
79 | * plasma lipoprotein particle assembly (GO:0034377) | 4.03073862 |
80 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02144123 |
81 | serine family amino acid biosynthetic process (GO:0009070) | 4.01399087 |
82 | regulation of bile acid biosynthetic process (GO:0070857) | 4.01092082 |
83 | cellular modified amino acid catabolic process (GO:0042219) | 3.99630714 |
84 | proline metabolic process (GO:0006560) | 3.99154625 |
85 | positive regulation of hemostasis (GO:1900048) | 3.98791755 |
86 | positive regulation of blood coagulation (GO:0030194) | 3.98791755 |
87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.98540820 |
88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.98540820 |
89 | benzene-containing compound metabolic process (GO:0042537) | 3.98198458 |
90 | ethanol oxidation (GO:0006069) | 3.97352299 |
91 | positive regulation of lipid catabolic process (GO:0050996) | 3.95001876 |
92 | * cholesterol homeostasis (GO:0042632) | 3.89805225 |
93 | arginine metabolic process (GO:0006525) | 3.88632984 |
94 | fibrinolysis (GO:0042730) | 3.88538797 |
95 | positive regulation of steroid metabolic process (GO:0045940) | 3.86782366 |
96 | regulation of cholesterol homeostasis (GO:2000188) | 3.84561007 |
97 | positive regulation of extracellular matrix organization (GO:1903055) | 3.83516706 |
98 | * sterol homeostasis (GO:0055092) | 3.83330665 |
99 | uronic acid metabolic process (GO:0006063) | 3.82448284 |
100 | glucuronate metabolic process (GO:0019585) | 3.82448284 |
101 | negative regulation of coagulation (GO:0050819) | 3.82382265 |
102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77421743 |
103 | aldehyde catabolic process (GO:0046185) | 3.76978902 |
104 | * lipoprotein metabolic process (GO:0042157) | 3.70126210 |
105 | negative regulation of complement activation (GO:0045916) | 3.67627902 |
106 | epoxygenase P450 pathway (GO:0019373) | 3.66960990 |
107 | ketone body metabolic process (GO:1902224) | 3.66051946 |
108 | * sterol transport (GO:0015918) | 3.65673126 |
109 | * cholesterol transport (GO:0030301) | 3.65673126 |
110 | organic acid catabolic process (GO:0016054) | 3.65650002 |
111 | carboxylic acid catabolic process (GO:0046395) | 3.65650002 |
112 | protein activation cascade (GO:0072376) | 3.65591788 |
113 | flavonoid metabolic process (GO:0009812) | 3.65303612 |
114 | positive regulation of coagulation (GO:0050820) | 3.65005733 |
115 | complement activation, classical pathway (GO:0006958) | 3.64078678 |
116 | acetyl-CoA metabolic process (GO:0006084) | 3.63543207 |
117 | complement activation (GO:0006956) | 3.62937596 |
118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.62823743 |
119 | * protein-lipid complex assembly (GO:0065005) | 3.62793011 |
120 | negative regulation of lipase activity (GO:0060192) | 3.62582974 |
121 | negative regulation of protein activation cascade (GO:2000258) | 3.61482538 |
122 | negative regulation of wound healing (GO:0061045) | 3.60403560 |
123 | cofactor catabolic process (GO:0051187) | 3.60087021 |
124 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.58968031 |
125 | * plasma lipoprotein particle organization (GO:0071827) | 3.58703069 |
126 | response to nitrosative stress (GO:0051409) | 3.55560313 |
127 | proline biosynthetic process (GO:0006561) | 3.41390496 |
128 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.36511505 |
129 | * lipid homeostasis (GO:0055088) | 3.29817377 |
130 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.23000684 |
131 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.19558362 |
132 | angiotensin maturation (GO:0002003) | 3.17880371 |
133 | drug transmembrane transport (GO:0006855) | 3.15966271 |
134 | regulation of extracellular matrix organization (GO:1903053) | 3.15964766 |
135 | negative regulation of sodium ion transport (GO:0010766) | 3.14353388 |
136 | cytolysis (GO:0019835) | 3.12931139 |
137 | negative regulation of lipid transport (GO:0032369) | 3.12834495 |
138 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.04583587 |
139 | modified amino acid transport (GO:0072337) | 3.04546430 |
140 | COPII vesicle coating (GO:0048208) | 3.03988047 |
141 | L-ascorbic acid metabolic process (GO:0019852) | 3.03243300 |
142 | drinking behavior (GO:0042756) | 3.01874469 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.23828499 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09410357 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.94015975 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53246327 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.17441986 |
6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.87958167 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.55144028 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.14198237 |
9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.75310263 |
10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.07592456 |
11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.33197237 |
12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.20264170 |
13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.08686113 |
14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07139695 |
15 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.05637291 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6836436 |
17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84281557 |
18 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.81572353 |
19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72760057 |
20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71275530 |
21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.67213361 |
22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65341282 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57459467 |
24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53150157 |
25 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.50321936 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46844057 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27675268 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26991018 |
29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22441287 |
30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19727971 |
31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19582934 |
32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18790992 |
33 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17846540 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16380130 |
35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11722184 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11712462 |
37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10505008 |
38 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.10491652 |
39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07811447 |
40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03792650 |
41 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.98360554 |
42 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95618082 |
43 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94194758 |
44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94040574 |
45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90630009 |
46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90433765 |
47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89070055 |
48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88437626 |
49 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.87232887 |
50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85588278 |
51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85489318 |
52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.84704861 |
53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83519812 |
54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82778077 |
55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82618705 |
56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81869074 |
57 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79923866 |
58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78428591 |
59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76991233 |
60 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76782376 |
61 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.75898707 |
62 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.75704503 |
63 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74236886 |
64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72961391 |
65 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.72458931 |
66 | TP53_16413492_ChIP-PET_HCT116_Human | 0.72371598 |
67 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.72185219 |
68 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72156765 |
69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71683184 |
70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71594790 |
71 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71269914 |
72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.71097981 |
73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70877742 |
74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70877742 |
75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70556809 |
76 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.70262163 |
77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70166439 |
78 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.67583709 |
79 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.67474716 |
80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.67179250 |
81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65461759 |
82 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.64682376 |
83 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.64083119 |
84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63501766 |
85 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.61426999 |
86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.60557463 |
87 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60413151 |
88 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.59607974 |
89 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.59402332 |
90 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.58673014 |
91 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58270423 |
92 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58253647 |
93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57571332 |
94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.57507337 |
95 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57348379 |
96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57340191 |
97 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57302012 |
98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57004433 |
99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.56795700 |
100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56445264 |
101 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.55985328 |
102 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.55876637 |
103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55757533 |
104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.55464559 |
105 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.54950146 |
106 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.54902732 |
107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54727918 |
108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54292735 |
109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53856477 |
110 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52116954 |
111 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51912085 |
112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51594328 |
113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.51332012 |
114 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51274519 |
115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51056202 |
116 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.50399873 |
117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50166526 |
118 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50074095 |
119 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49695009 |
120 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.48262990 |
121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48259160 |
122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.47247157 |
123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.46485342 |
124 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46437466 |
125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.45756024 |
126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43895650 |
127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.42923645 |
128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42844860 |
129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.41183171 |
130 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40490437 |
131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40423270 |
132 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39986142 |
133 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39498880 |
134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39184970 |
135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.38669748 |
136 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.37982304 |
137 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.37089333 |
138 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35297664 |
139 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.34338914 |
140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34214467 |
141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.34100499 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.16273923 |
2 | MP0005360_urolithiasis | 7.97884854 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.47702944 |
4 | MP0005365_abnormal_bile_salt | 6.15278938 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.98110477 |
6 | MP0003122_maternal_imprinting | 4.31983453 |
7 | MP0003252_abnormal_bile_duct | 4.12412611 |
8 | MP0003806_abnormal_nucleotide_metabolis | 4.07445673 |
9 | * MP0010329_abnormal_lipoprotein_level | 3.52269709 |
10 | MP0009840_abnormal_foam_cell | 3.31553674 |
11 | MP0001666_abnormal_nutrient_absorption | 3.03467756 |
12 | MP0005083_abnormal_biliary_tract | 3.00460984 |
13 | MP0005332_abnormal_amino_acid | 2.66199205 |
14 | MP0003195_calcinosis | 2.56141202 |
15 | MP0003123_paternal_imprinting | 2.33653906 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.24691263 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.23764258 |
18 | MP0000566_synostosis | 2.16308126 |
19 | * MP0000609_abnormal_liver_physiology | 2.13226033 |
20 | MP0002118_abnormal_lipid_homeostasis | 2.07235389 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.97043529 |
22 | MP0002089_abnormal_postnatal_growth/wei | 1.92050608 |
23 | MP0003868_abnormal_feces_composition | 1.88662663 |
24 | MP0005319_abnormal_enzyme/_coenzyme | 1.76016800 |
25 | MP0005058_abnormal_lysosome_morphology | 1.74428331 |
26 | MP0001915_intracranial_hemorrhage | 1.72647906 |
27 | MP0009697_abnormal_copulation | 1.71029403 |
28 | MP0005409_darkened_coat_color | 1.69460613 |
29 | MP0006054_spinal_hemorrhage | 1.69042333 |
30 | MP0003172_abnormal_lysosome_physiology | 1.63819875 |
31 | MP0003183_abnormal_peptide_metabolism | 1.60454299 |
32 | MP0001764_abnormal_homeostasis | 1.59100974 |
33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48630469 |
34 | MP0003121_genomic_imprinting | 1.35171794 |
35 | MP0005451_abnormal_body_composition | 1.34115129 |
36 | MP0002132_abnormal_respiratory_system | 1.30536291 |
37 | MP0004272_abnormal_basement_membrane | 1.29347005 |
38 | MP0003011_delayed_dark_adaptation | 1.27785901 |
39 | MP0009643_abnormal_urine_homeostasis | 1.23457201 |
40 | MP0003705_abnormal_hypodermis_morpholog | 1.22010830 |
41 | MP0002254_reproductive_system_inflammat | 1.19212274 |
42 | MP0003656_abnormal_erythrocyte_physiolo | 1.14196940 |
43 | * MP0000598_abnormal_liver_morphology | 1.13007421 |
44 | MP0009780_abnormal_chondrocyte_physiolo | 1.12051996 |
45 | MP0003186_abnormal_redox_activity | 1.08947317 |
46 | MP0000604_amyloidosis | 1.08244994 |
47 | MP0003950_abnormal_plasma_membrane | 1.05426132 |
48 | MP0005647_abnormal_sex_gland | 1.02475170 |
49 | MP0009764_decreased_sensitivity_to | 1.00810203 |
50 | MP0005084_abnormal_gallbladder_morpholo | 0.99533650 |
51 | MP0005257_abnormal_intraocular_pressure | 0.98822835 |
52 | MP0003315_abnormal_perineum_morphology | 0.96859825 |
53 | MP0009763_increased_sensitivity_to | 0.96769734 |
54 | MP0005636_abnormal_mineral_homeostasis | 0.92956565 |
55 | MP0010368_abnormal_lymphatic_system | 0.87547572 |
56 | MP0003941_abnormal_skin_development | 0.86273021 |
57 | MP0005167_abnormal_blood-brain_barrier | 0.86217644 |
58 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85557550 |
59 | MP0008469_abnormal_protein_level | 0.85026735 |
60 | * MP0009642_abnormal_blood_homeostasis | 0.84270265 |
61 | MP0005408_hypopigmentation | 0.84209526 |
62 | MP0005376_homeostasis/metabolism_phenot | 0.79464822 |
63 | MP0009765_abnormal_xenobiotic_induced | 0.79338184 |
64 | MP0002938_white_spotting | 0.75625794 |
65 | * MP0002078_abnormal_glucose_homeostasis | 0.73694611 |
66 | MP0005220_abnormal_exocrine_pancreas | 0.73076162 |
67 | MP0001270_distended_abdomen | 0.72835446 |
68 | MP0002933_joint_inflammation | 0.72012090 |
69 | MP0009053_abnormal_anal_canal | 0.71658499 |
70 | MP0005076_abnormal_cell_differentiation | 0.71033632 |
71 | MP0002876_abnormal_thyroid_physiology | 0.70810025 |
72 | MP0002971_abnormal_brown_adipose | 0.69980235 |
73 | MP0006036_abnormal_mitochondrial_physio | 0.69334169 |
74 | MP0005334_abnormal_fat_pad | 0.67880320 |
75 | MP0005266_abnormal_metabolism | 0.67139283 |
76 | MP0001661_extended_life_span | 0.67090716 |
77 | MP0004130_abnormal_muscle_cell | 0.66547306 |
78 | MP0005448_abnormal_energy_balance | 0.65761149 |
79 | MP0003632_abnormal_nervous_system | 0.65394291 |
80 | MP0003890_abnormal_embryonic-extraembry | 0.64174387 |
81 | MP0005670_abnormal_white_adipose | 0.63843786 |
82 | MP0003943_abnormal_hepatobiliary_system | 0.63035473 |
83 | MP0003690_abnormal_glial_cell | 0.61746506 |
84 | MP0005535_abnormal_body_temperature | 0.61486468 |
85 | MP0002909_abnormal_adrenal_gland | 0.61261509 |
86 | MP0004264_abnormal_extraembryonic_tissu | 0.60597335 |
87 | MP0000920_abnormal_myelination | 0.60120828 |
88 | MP0003879_abnormal_hair_cell | 0.60096940 |
89 | MP0003329_amyloid_beta_deposits | 0.59935723 |
90 | MP0003115_abnormal_respiratory_system | 0.58034455 |
91 | MP0003566_abnormal_cell_adhesion | 0.57885092 |
92 | MP0001756_abnormal_urination | 0.57045814 |
93 | MP0005164_abnormal_response_to | 0.56633583 |
94 | MP0006035_abnormal_mitochondrial_morpho | 0.56353208 |
95 | MP0002822_catalepsy | 0.55240759 |
96 | MP0005464_abnormal_platelet_physiology | 0.55238805 |
97 | MP0000639_abnormal_adrenal_gland | 0.54849764 |
98 | MP0010234_abnormal_vibrissa_follicle | 0.54309921 |
99 | MP0005023_abnormal_wound_healing | 0.51999957 |
100 | MP0003942_abnormal_urinary_system | 0.51739379 |
101 | MP0000003_abnormal_adipose_tissue | 0.49492578 |
102 | MP0002136_abnormal_kidney_physiology | 0.48730203 |
103 | MP0009384_cardiac_valve_regurgitation | 0.48279288 |
104 | MP0003718_maternal_effect | 0.48039555 |
105 | MP0002928_abnormal_bile_duct | 0.47704371 |
106 | MP0003878_abnormal_ear_physiology | 0.47542262 |
107 | MP0005377_hearing/vestibular/ear_phenot | 0.47542262 |
108 | MP0005395_other_phenotype | 0.45872283 |
109 | MP0008260_abnormal_autophagy | 0.44851151 |
110 | MP0002697_abnormal_eye_size | 0.44730431 |
111 | MP0003638_abnormal_response/metabolism_ | 0.44062859 |
112 | MP0008873_increased_physiological_sensi | 0.43587650 |
113 | MP0001730_embryonic_growth_arrest | 0.43216307 |
114 | MP0002092_abnormal_eye_morphology | 0.42740449 |
115 | MP0002796_impaired_skin_barrier | 0.42429843 |
116 | MP0000858_altered_metastatic_potential | 0.41930108 |
117 | MP0002166_altered_tumor_susceptibility | 0.40717039 |
118 | MP0000579_abnormal_nail_morphology | 0.40118562 |
119 | MP0003699_abnormal_female_reproductive | 0.39663789 |
120 | MP0005248_abnormal_Harderian_gland | 0.39637878 |
121 | MP0005166_decreased_susceptibility_to | 0.38177109 |
122 | * MP0002086_abnormal_extraembryonic_tissu | 0.37801388 |
123 | * MP0003953_abnormal_hormone_level | 0.37532519 |
124 | MP0008874_decreased_physiological_sensi | 0.37246315 |
125 | MP0003436_decreased_susceptibility_to | 0.37237849 |
126 | MP0003724_increased_susceptibility_to | 0.37168587 |
127 | MP0000371_diluted_coat_color | 0.36483757 |
128 | MP0004782_abnormal_surfactant_physiolog | 0.36291669 |
129 | MP0004381_abnormal_hair_follicle | 0.36144359 |
130 | MP0005666_abnormal_adipose_tissue | 0.35483660 |
131 | MP0000427_abnormal_hair_cycle | 0.33989835 |
132 | MP0000230_abnormal_systemic_arterial | 0.33548015 |
133 | MP0009115_abnormal_fat_cell | 0.33522888 |
134 | MP0003075_altered_response_to | 0.33448762 |
135 | MP0001881_abnormal_mammary_gland | 0.32784152 |
136 | MP0008872_abnormal_physiological_respon | 0.32515478 |
137 | MP0009672_abnormal_birth_weight | 0.31914109 |
138 | MP0000249_abnormal_blood_vessel | 0.31198322 |
139 | MP0004883_abnormal_blood_vessel | 0.30252176 |
140 | MP0001243_abnormal_dermal_layer | 0.29965207 |
141 | MP0003300_gastrointestinal_ulcer | 0.29069159 |
142 | MP0001853_heart_inflammation | 0.27442795 |
143 | MP0001845_abnormal_inflammatory_respons | 0.27107076 |
144 | MP0002060_abnormal_skin_morphology | 0.27100143 |
145 | MP0004043_abnormal_pH_regulation | 0.27004353 |
146 | MP0002970_abnormal_white_adipose | 0.26540379 |
147 | MP0006082_CNS_inflammation | 0.26440451 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.61929972 |
2 | Deep venous thrombosis (HP:0002625) | 7.31491865 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.95111685 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.75676291 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.55497787 |
6 | * Hypobetalipoproteinemia (HP:0003563) | 6.25001191 |
7 | * Xanthomatosis (HP:0000991) | 6.05438427 |
8 | Complement deficiency (HP:0004431) | 5.41117560 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.18626601 |
10 | Joint hemorrhage (HP:0005261) | 4.71865021 |
11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.70766101 |
12 | * Hypolipoproteinemia (HP:0010981) | 4.66217584 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.63074954 |
14 | Hyperammonemia (HP:0001987) | 4.60499994 |
15 | Conjugated hyperbilirubinemia (HP:0002908) | 4.40338378 |
16 | Hyperglycinemia (HP:0002154) | 4.32022488 |
17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27933581 |
18 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.25961636 |
19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22833352 |
20 | Hypoalphalipoproteinemia (HP:0003233) | 4.17874307 |
21 | * Fat malabsorption (HP:0002630) | 4.15434819 |
22 | Abnormality of methionine metabolism (HP:0010901) | 4.12381077 |
23 | Ketosis (HP:0001946) | 4.07246134 |
24 | Hyperglycinuria (HP:0003108) | 4.03532205 |
25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.97397398 |
26 | Abnormality of glycine metabolism (HP:0010895) | 3.97397398 |
27 | * Epidermoid cyst (HP:0200040) | 3.97209291 |
28 | Hypoglycemic coma (HP:0001325) | 3.95725511 |
29 | Abnormality of complement system (HP:0005339) | 3.93896219 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79325670 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.74787860 |
32 | Abnormality of carpal bone ossification (HP:0006257) | 3.57786179 |
33 | Small epiphyses (HP:0010585) | 3.55220127 |
34 | Abnormal tarsal ossification (HP:0008369) | 3.50061759 |
35 | Hyperbilirubinemia (HP:0002904) | 3.44154142 |
36 | * Hypercholesterolemia (HP:0003124) | 3.41714426 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29581580 |
38 | Flat acetabular roof (HP:0003180) | 3.23778879 |
39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18957654 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09774829 |
41 | Spontaneous abortion (HP:0005268) | 3.08230201 |
42 | Steatorrhea (HP:0002570) | 3.08208222 |
43 | Hepatocellular carcinoma (HP:0001402) | 3.02601652 |
44 | Broad alveolar ridges (HP:0000187) | 3.01491806 |
45 | Ketoacidosis (HP:0001993) | 2.97256706 |
46 | Abnormality of serum amino acid levels (HP:0003112) | 2.95822023 |
47 | Myocardial infarction (HP:0001658) | 2.95743658 |
48 | Hypochromic microcytic anemia (HP:0004840) | 2.93513254 |
49 | Delayed CNS myelination (HP:0002188) | 2.92377838 |
50 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.80515395 |
51 | Broad palm (HP:0001169) | 2.79970440 |
52 | Purpura (HP:0000979) | 2.79827099 |
53 | Hypophosphatemic rickets (HP:0004912) | 2.78916227 |
54 | Metabolic acidosis (HP:0001942) | 2.76335864 |
55 | Abnormality of purine metabolism (HP:0004352) | 2.74999409 |
56 | Hypoglycemic seizures (HP:0002173) | 2.70977982 |
57 | Systemic lupus erythematosus (HP:0002725) | 2.70761573 |
58 | Osteomalacia (HP:0002749) | 2.67604764 |
59 | Abnormal hand bone ossification (HP:0010660) | 2.66902821 |
60 | Malnutrition (HP:0004395) | 2.64568496 |
61 | Abnormal ossification of hand bones (HP:0005921) | 2.64422797 |
62 | Hepatoblastoma (HP:0002884) | 2.61035569 |
63 | Glomerulonephritis (HP:0000099) | 2.54881300 |
64 | Vascular calcification (HP:0004934) | 2.54310715 |
65 | Lethargy (HP:0001254) | 2.52082004 |
66 | Abnormality of the nasal septum (HP:0000419) | 2.51834469 |
67 | Facial shape deformation (HP:0011334) | 2.51660649 |
68 | Potter facies (HP:0002009) | 2.51660649 |
69 | Abnormal gallbladder morphology (HP:0012437) | 2.51517072 |
70 | Spastic diplegia (HP:0001264) | 2.49601342 |
71 | Increased serum pyruvate (HP:0003542) | 2.49283138 |
72 | Epiphyseal dysplasia (HP:0002656) | 2.48201099 |
73 | Cholecystitis (HP:0001082) | 2.46046447 |
74 | Abnormal gallbladder physiology (HP:0012438) | 2.46046447 |
75 | Cholelithiasis (HP:0001081) | 2.45244265 |
76 | Abnormality of the lumbar spine (HP:0100712) | 2.41531924 |
77 | Dicarboxylic aciduria (HP:0003215) | 2.40467157 |
78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40467157 |
79 | Esophageal varix (HP:0002040) | 2.37869214 |
80 | Irritability (HP:0000737) | 2.34372800 |
81 | Widely patent fontanelles and sutures (HP:0004492) | 2.32406680 |
82 | Cerebral edema (HP:0002181) | 2.31978667 |
83 | * Skin nodule (HP:0200036) | 2.31835995 |
84 | Arthropathy (HP:0003040) | 2.31349077 |
85 | Pigmentary retinal degeneration (HP:0001146) | 2.30633465 |
86 | Abnormality of glycolysis (HP:0004366) | 2.30285840 |
87 | Abnormal foot bone ossification (HP:0010675) | 2.30250137 |
88 | Amyloidosis (HP:0011034) | 2.29951474 |
89 | * Acanthocytosis (HP:0001927) | 2.29868079 |
90 | Gout (HP:0001997) | 2.29844616 |
91 | Gingival bleeding (HP:0000225) | 2.27787157 |
92 | Mitral stenosis (HP:0001718) | 2.26470631 |
93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25328418 |
94 | Cardiovascular calcification (HP:0011915) | 2.25271915 |
95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.21065035 |
96 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.21060647 |
97 | Neonatal onset (HP:0003623) | 2.19784345 |
98 | Hydroxyprolinuria (HP:0003080) | 2.19510671 |
99 | Abnormality of proline metabolism (HP:0010907) | 2.19510671 |
100 | Sensorimotor neuropathy (HP:0007141) | 2.19201216 |
101 | Vaginal fistula (HP:0004320) | 2.18781030 |
102 | Pancreatitis (HP:0001733) | 2.17089361 |
103 | Diastasis recti (HP:0001540) | 2.16198144 |
104 | Alacrima (HP:0000522) | 2.13690363 |
105 | Abnormality of the wing of the ilium (HP:0011867) | 2.13308143 |
106 | Flared iliac wings (HP:0002869) | 2.12074292 |
107 | Late onset (HP:0003584) | 2.11305754 |
108 | Menorrhagia (HP:0000132) | 2.11033444 |
109 | Enlarged kidneys (HP:0000105) | 2.05366982 |
110 | Thrombophlebitis (HP:0004418) | 2.04997377 |
111 | Irregular epiphyses (HP:0010582) | 2.04987066 |
112 | Brushfield spots (HP:0001088) | 2.02031354 |
113 | Cupped ribs (HP:0000887) | 2.01506474 |
114 | * Poikilocytosis (HP:0004447) | 2.01360017 |
115 | Abnormality of the gallbladder (HP:0005264) | 2.00504698 |
116 | Asymmetry of the thorax (HP:0001555) | 2.00490270 |
117 | Proximal tubulopathy (HP:0000114) | 1.99352173 |
118 | Rickets (HP:0002748) | 1.99254973 |
119 | Hemorrhage of the eye (HP:0011885) | 1.99099522 |
120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98091994 |
121 | Vomiting (HP:0002013) | 1.97364915 |
122 | Abnormality of vitamin metabolism (HP:0100508) | 1.96538810 |
123 | Generalized aminoaciduria (HP:0002909) | 1.92911240 |
124 | Metaphyseal irregularity (HP:0003025) | 1.92239444 |
125 | Abnormality of iron homeostasis (HP:0011031) | 1.91977647 |
126 | Opisthotonus (HP:0002179) | 1.90056279 |
127 | Abnormal cartilage morphology (HP:0002763) | 1.88968110 |
128 | Nephritis (HP:0000123) | 1.88392222 |
129 | Abnormal delivery (HP:0001787) | 1.87563924 |
130 | Alkalosis (HP:0001948) | 1.87297291 |
131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87063254 |
132 | Confusion (HP:0001289) | 1.86533709 |
133 | Symptomatic seizures (HP:0011145) | 1.85501231 |
134 | Abnormality of urine glucose concentration (HP:0011016) | 1.85095807 |
135 | Glycosuria (HP:0003076) | 1.85095807 |
136 | Hyperglycemia (HP:0003074) | 1.83020404 |
137 | Neonatal death (HP:0003811) | 1.83018874 |
138 | Absent epiphyses (HP:0010577) | 1.81966747 |
139 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.81966747 |
140 | Abnormality of the acetabulum (HP:0003170) | 1.81876178 |
141 | Joint swelling (HP:0001386) | 1.77815931 |
142 | Wide nose (HP:0000445) | 1.76908937 |
143 | Limited elbow extension (HP:0001377) | 1.76218614 |
144 | Wide cranial sutures (HP:0010537) | 1.75415906 |
145 | Prenatal maternal abnormality (HP:0002686) | 1.70301016 |
146 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.69262677 |
147 | Abnormality of the Achilles tendon (HP:0005109) | 1.69197799 |
148 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.68176917 |
149 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.68176917 |
150 | Peritonitis (HP:0002586) | 1.66781798 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.10080768 |
2 | SIK1 | 4.49304482 |
3 | FGFR4 | 4.16919174 |
4 | ERN1 | 3.71440449 |
5 | INSRR | 3.42978678 |
6 | TAOK3 | 3.20960141 |
7 | ERBB4 | 3.18883249 |
8 | WNK4 | 3.09535724 |
9 | CDK12 | 3.08490083 |
10 | FRK | 2.88729797 |
11 | MST1R | 2.83538564 |
12 | TYRO3 | 2.64441821 |
13 | FGFR1 | 2.29661602 |
14 | MAP2K4 | 2.14686680 |
15 | LATS1 | 2.11618191 |
16 | PKN2 | 2.07732505 |
17 | MAPK11 | 2.04452822 |
18 | PIK3CG | 1.97719461 |
19 | FLT3 | 1.78855299 |
20 | PTK6 | 1.76125321 |
21 | TYK2 | 1.65583192 |
22 | MAP3K10 | 1.59528389 |
23 | FGFR2 | 1.54895582 |
24 | WNK1 | 1.52818034 |
25 | EEF2K | 1.52332936 |
26 | DAPK2 | 1.45194597 |
27 | GRK6 | 1.42317398 |
28 | MAP3K7 | 1.39600745 |
29 | TRIB3 | 1.39241253 |
30 | NEK9 | 1.37982820 |
31 | EIF2AK1 | 1.33869992 |
32 | ABL2 | 1.31299305 |
33 | PRKAA2 | 1.28550470 |
34 | ERBB2 | 1.27599055 |
35 | KDR | 1.24480675 |
36 | DDR2 | 1.23196108 |
37 | JAK2 | 1.21391714 |
38 | SIK2 | 1.18681568 |
39 | MET | 1.18342669 |
40 | RIPK1 | 1.16255356 |
41 | STK39 | 1.13721340 |
42 | JAK1 | 1.06496762 |
43 | PDK2 | 1.03465050 |
44 | ACVR1B | 1.01961832 |
45 | CAMK1D | 0.98915706 |
46 | LATS2 | 0.98488327 |
47 | TBK1 | 0.97940742 |
48 | MAPK4 | 0.95126545 |
49 | CDK7 | 0.93697750 |
50 | MAP3K14 | 0.89591701 |
51 | EPHB1 | 0.88923714 |
52 | NEK1 | 0.86420791 |
53 | PINK1 | 0.85673090 |
54 | FGR | 0.84426167 |
55 | PRKCZ | 0.84384625 |
56 | RPS6KB1 | 0.83080106 |
57 | MAP3K3 | 0.83067651 |
58 | KSR2 | 0.81815707 |
59 | CDK6 | 0.81765371 |
60 | CSNK1E | 0.79896715 |
61 | MAPKAPK3 | 0.79278897 |
62 | MAP2K3 | 0.79242811 |
63 | PRKAA1 | 0.77145376 |
64 | AKT3 | 0.76308053 |
65 | PRKACG | 0.75835480 |
66 | STK38L | 0.75572725 |
67 | EPHA3 | 0.71583969 |
68 | FGFR3 | 0.70603683 |
69 | BRSK2 | 0.70055855 |
70 | SGK3 | 0.69108504 |
71 | GSK3A | 0.68813859 |
72 | CAMK2G | 0.67748813 |
73 | SGK1 | 0.67268908 |
74 | CSK | 0.67101744 |
75 | DYRK1B | 0.67021761 |
76 | NEK2 | 0.66012565 |
77 | CDC42BPA | 0.64911615 |
78 | PTK2 | 0.64735904 |
79 | BCR | 0.64610612 |
80 | MAP3K2 | 0.63396397 |
81 | BRSK1 | 0.62824565 |
82 | SCYL2 | 0.62612997 |
83 | MAPK12 | 0.62054615 |
84 | SMG1 | 0.61291409 |
85 | TIE1 | 0.60359677 |
86 | MAP3K11 | 0.60245808 |
87 | BRD4 | 0.58897589 |
88 | CSF1R | 0.58148044 |
89 | EPHA2 | 0.57415284 |
90 | MAP2K6 | 0.55022680 |
91 | PRKCQ | 0.55012975 |
92 | MAPK15 | 0.54859190 |
93 | PDPK1 | 0.53192852 |
94 | NTRK3 | 0.51726630 |
95 | IRAK3 | 0.50204319 |
96 | NUAK1 | 0.50052254 |
97 | GRK1 | 0.49825230 |
98 | MATK | 0.49756373 |
99 | MAPK7 | 0.48179956 |
100 | SGK2 | 0.47353052 |
101 | IGF1R | 0.47016108 |
102 | CSNK1G1 | 0.46151111 |
103 | MAP2K1 | 0.45323469 |
104 | MAP3K1 | 0.45165296 |
105 | YES1 | 0.44742011 |
106 | TGFBR2 | 0.44660547 |
107 | RET | 0.43438978 |
108 | PIK3CA | 0.42920659 |
109 | IKBKE | 0.42919997 |
110 | SRC | 0.41932393 |
111 | ICK | 0.40888356 |
112 | PKN1 | 0.40450788 |
113 | CDK8 | 0.40223113 |
114 | MAP3K5 | 0.39199013 |
115 | CAMK1G | 0.38633914 |
116 | MTOR | 0.38628814 |
117 | CSNK1D | 0.38276692 |
118 | MELK | 0.38205623 |
119 | EGFR | 0.38061672 |
120 | NLK | 0.37502843 |
121 | MAP2K2 | 0.37154802 |
122 | PRKG2 | 0.37152047 |
123 | PBK | 0.36791345 |
124 | BMX | 0.35984066 |
125 | CDK4 | 0.35451136 |
126 | PDK1 | 0.35180570 |
127 | CSNK2A2 | 0.35122776 |
128 | PDGFRB | 0.33889868 |
129 | LMTK2 | 0.33753108 |
130 | STK3 | 0.33710033 |
131 | PAK3 | 0.32678941 |
132 | SGK223 | 0.30446409 |
133 | SGK494 | 0.30446409 |
134 | RPS6KA3 | 0.29010639 |
135 | CSNK2A1 | 0.28444773 |
136 | PRKCA | 0.28371934 |
137 | MAP3K6 | 0.28191775 |
138 | MAP3K13 | 0.27819068 |
139 | PRKG1 | 0.27551153 |
140 | EPHA4 | 0.26648284 |
141 | EIF2AK3 | 0.25665888 |
142 | ALK | 0.25651010 |
143 | PDGFRA | 0.25165047 |
144 | NTRK2 | 0.24301247 |
145 | CAMK4 | 0.23740167 |
146 | PRKCG | 0.23465240 |
147 | ABL1 | 0.22723506 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37069934 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.13269152 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33620077 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25338860 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.10914032 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71452343 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66689152 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62453488 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52286387 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50553963 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45256595 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29014381 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20668669 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09176620 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06410485 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.02070697 |
17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95652963 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91311020 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86624308 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83906314 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82645036 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82572080 |
23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81922394 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79812595 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73193018 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72369262 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71971741 |
28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71308945 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69528971 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65890207 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.61097887 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55776302 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49791030 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48930290 |
35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46683197 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46176318 |
37 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.42771928 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40062219 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37818559 |
40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34866933 |
41 | ABC transporters_Homo sapiens_hsa02010 | 1.34615713 |
42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33980778 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32564652 |
44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29569930 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23013658 |
46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22248301 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18406395 |
48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15767180 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13972939 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12302214 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98324458 |
52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95844710 |
53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95529585 |
54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94492660 |
55 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93120563 |
56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92932444 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89920652 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88993143 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.85537159 |
60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84271645 |
61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78029700 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77314191 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74997048 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73315326 |
65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68982400 |
66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68965280 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63460988 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57888483 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50197245 |
70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49029136 |
71 | Pertussis_Homo sapiens_hsa05133 | 0.44055853 |
72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43786890 |
73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40352353 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32368320 |
75 | Prion diseases_Homo sapiens_hsa05020 | 0.29840225 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.26162580 |
77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25043305 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23171974 |
79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.19457755 |
80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19110881 |
81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17722997 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14874122 |
83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13200567 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11825685 |
85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09425992 |
86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02387206 |
87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.01544188 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.01499097 |
89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.01445439 |
90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.01177292 |
91 | Mineral absorption_Homo sapiens_hsa04978 | 0.00189437 |
92 | Amoebiasis_Homo sapiens_hsa05146 | -0.2247016 |
93 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2213943 |
94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2115133 |
95 | Bladder cancer_Homo sapiens_hsa05219 | -0.2052126 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2003574 |
97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1925202 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1808242 |
99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1521083 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1502720 |
101 | Hepatitis C_Homo sapiens_hsa05160 | -0.1481516 |
102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1318904 |
103 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1260634 |
104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1196753 |
105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1115942 |
106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1066355 |
107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0872963 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0805534 |
109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0444800 |
110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0159426 |